Tuberculosis bacteria mutate while airborne and drying, according to research from Weill Cornell Medicine that reveals how the pathogen generates antibiotic resistance during transmission. The discovery opens new avenues for disrupting drug-resistant tuberculosis before it reaches a new host.
When infected individuals cough or sneeze, they expel TB bacteria suspended in respiratory droplets. These particles dry rapidly in air, forming nuclei that remain infectious. The bacteria rank second only to measles in transmissibility, infecting roughly a quarter of the global population and killing more than a million people annually. But the drying process itself, researchers found, triggers molecular changes that accelerate mutation rates tied to drug resistance.
"This suggests that transmission involves more than the passive movement of bacteria between people and may be a period during which the pathogen evolves," the Weill Cornell team explained in their findings. The researchers identified specific cellular mechanisms bacteria activate during desiccation, the process of drying out. These mechanisms include stress response pathways that leave DNA more vulnerable to mutations.
The significance lies in timing. Previously, scientists assumed mutations conferring drug resistance arose randomly over the course of an infection within a host. The Weill Cornell work indicates that the airborne phase itself, typically lasting minutes to hours depending on conditions, accelerates this process. A single infected person may expel hundreds of thousands of bacterial particles during a cough. If the drying phase amplifies mutation rates, then even untreated infections generate more resistant variants during each transmission event.
This discovery has direct implications for tuberculosis control. Current treatment regimens require multiple antibiotics taken for months, and incomplete courses fuel resistance. If bacteria are already mutating during air transmission, blocking or slowing this process could reduce the emergence of resistant strains before they establish new infections. Researchers might develop compounds that inhibit the stress-response pathways bacteria activate during desiccation, essentially trapping them in a vulnerable state before they dry completely.
Drug-resistant TB remains a public health crisis. Multidrug-resistant tuberculosis, or MDR-TB, fails to respond to first-line antibiotics. Extensively drug-resistant tuberculosis, or XDR-TB, resists even second-line drugs. The World Health Organization estimated 450,000 MDR-TB cases in 2022 alone. Any intervention that reduces mutation rates during transmission could bend the curve on resistance development.
The Weill Cornell findings also reframe how scientists understand TB epidemiology. Transmission has been studied largely from the perspective of infectious load, air circulation, and host immunity. The recognition that bacteria actively evolve during the journey between hosts adds a previously overlooked dimension to disease spread. It suggests that environmental conditions in shared air spaces, humidity levels, and ventilation might influence not just transmission risk but the genetic properties of bacteria that establish infection.
Laboratory validation of these mechanisms remains essential before clinical applications emerge. The team must confirm findings in animal models and determine whether interventions targeting desiccation-induced mutations reduce resistance in naturally infected populations. These steps typically require years of additional research.
Nonetheless, the discovery shifts therapeutic thinking. Instead of only treating established infections, researchers can now consider interrupting TB's evolutionary trajectory during its most vulnerable phase, before it settles into a new host.